Katja Boland

Association Between Citalopram Serum Levels and Clinical Improvement of Patients With Major Depression

Elnaz Ostad Haji, André Tadić, Stefanie Wagner et al. · Journal of Clinical Psychopharmacology · 2011 · 43 citations

Clinical Improvement, Psychopharmacology, Pharmacotherapy +17

Potential Cost-effectiveness of Therapeutic Drug Monitoring for Depressed Patients Treated With Citalopram

Elnaz Ostad Haji, Klaus Mann, Aleksandra Dragičević et al. · Therapeutic Drug Monitoring · 2013 · 33 citations

First‐in‐human study assessing safety, tolerability and pharmacokinetics of BI 409306, a selective phosphodiesterase 9A inhibitor, in healthy males

Viktoria Moschetti, Katja Boland, Ulrich Feifel et al. · British Journal of Clinical Pharmacology · 2016 · 30 citations · Full text

A phase I, randomized, proof‐of‐clinical‐mechanism study assessing the pharmacokinetics and pharmacodynamics of the oral <scp>PDE9A</scp> inhibitor <scp>BI</scp> 409306 in healthy male volunteers

Katja Boland, Viktoria Moschetti, C. Dansirikul et al. · Human Psychopharmacology Clinical and Experimental · 2017 · 29 citations

Randomized Placebo-Controlled Double-Blind Combined Therapy with Laser-Surgery and Systemic Interferon-Alpha-2A in the Treatment of Anogenital Condylomata Acuminatum

John Mendelson, Alex Ferenczy, James C. Arseneau et al. · Queensland's institutional digital repository (The University of Queensland) · 1993 · 27 citations

Surgical Oncology, Urology, Ophthalmology +13